Speranza Therapeutics

Speranza Therapeutics S.T. Genesis is an FDA-cleared medical device that reduces the physical and emotional strain of withdrawal experienced by those suffering from opioid use disorder. Utilizing neurostimulation treatment, the device reduces opioid withdrawal symptoms by targeting the areas of the brain responsible for pain and anxiety. 

The noninvasive, non-surgical, drug-free device is easily applied to the ear by a healthcare provider and administers treatment for 5 days helping the patient during the most critical time as they stop opioid use.  S.T. Genesis has proven clinical efficacy in reducing opioid withdrawal symptoms by up to 93% within the first hour, most occurring within 15 minutes. It can be used in an inpatient or outpatient setting and incorporated into MAT or abstinence treatment plans. 

S.T. Genesis manages withdrawal symptoms through detox and allows the patient to remain comfortable, engaged, and capable of staying in treatment longer. Current providers using S.T. Genesis report an average of 50% reduction in AMA rates compared to opioid replacement induction protocols, and 90% of those patients went on to longer term treatment programs in Residential Treatment Centers or through Intensive Outpatient Programs.